Keywords: roche, chugai, hep, drug, under, priority, review

Roche and Chugai hep C drug under priority review

Article | 19 September 2005

Print This

Swiss drug major Roche and its wholly-owned Japanese subsidiary Chugai say that the combination of Pegasys (peginterferon alfa-2a 40KD) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in